PORTLAND, Oregon, August 20, 2015 /PRNewswire/ --
Big Market research has added a report titled "Bioburden Testing Market by Product [Instrument (PCR, Microscopes), and Consumables (Kit, Reagent], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) and End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019". As per the report, bioburden testing market is forecast to reach a value of about $565.6 Million by the end of 2019 growing at 9.8% CAGR amid 2014-2019.
To get more information about this report visit @ http://www.bigmarketresearch.com/bioburden-testing-mnm-market
The report segments the bioburden testing market based on applications, products and services, end users, test types, and geography. When segmented on the basis of products, consumables segment amounted for the highest market share in 2014; while the culture media and reagents & kits segment is estimated to exhibit the maximum CAGR growth rate amid the forecast period due to the widespread adoption of the segment.
Based on geographical regions, North America dominates the bioburden testing market, followed by Asia, Europe and the Rest of the World (RoW). North America accounted for the maximum share of the market in the year 2014, while Asia-Pacific region is expected to show highest growth over the forecast period.
Remarkable growth in medical devices industry, favorable trends in the pharmaceutical and biotechnology industries, mounting food safety concerns, increased R&D investments in life sciences, and a rise in the rate of product recalls owing to microbial contamination are the prime drivers fueling the growth of the bioburden testing market.
Key market players profiled in the report are Charles River Laboratories International, Inc. (U.S.), SGS S.A. (Switzerland), Merck & Co. Inc. (U.S.), WuXi PharmaTech (Cayman) Inc. (China), North American Science Associates, Inc. (NAMSA) (U.S.), ATS Labs, Inc. (U.S.) and Nelson Laboratories (U.S.), amongst others.
Enquiry about this report visit @ http://www.bigmarketresearch.com/report-enquiry/280864
Browse Similar Studies:
Global Retinoblastoma Market
Cancer occurs when normal cells transform to evade the regular cell cycle process. Retinoblastoma is a rare eye cancer. It occurs in children of age less than 15 years; the disease is common in children younger than five years, especially children less than two years. The disease affects the retina and is caused by a mutation in the gene RB1. It usually appears in one eye and gradually spreads to the other. Clinically, retinoblastoma is classified into two: unilateral retinoblastoma, tumor in one eye, and bilateral retinoblastoma, tumor in both the eyes.
Global and Chinese Veterinary Diagnostic Industry
The current veterinary diagnostics market is largely characterized through the U.S. companion animal diagnostics market and European food animal diagnostics market. Companion animal diagnostics in Europe, rest of world companion diagnostics and food animal infectious disease diagnostics represent submarkets with significant potential for growth, also Chinese market. International trade, public health, agricultural productivity, consumer confidence and companion animal-owner relationships are all dependent upon effective and increasingly specialized veterinary diagnostics products.
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.
With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
Direct :+1 (617) 674-4143
Toll Free :+1 (855) 711-1555
Fax : +1 (855) 550-5975
SOURCE Big Market Research